Comparison of Gastric Insufflation Volume Using I-gel and Ambu AuraGain Devices in Children Ages 2 to 12 Undergoing Elective Orthopedic Surgery with General Anesthesia

What this Trial Is About

This research aims to compare two types of supraglottic airway devices, Ambu AuraGain and I-gel, in children aged 2 to 12 years undergoing elective orthopedic surgery under general anesthesia. The study focuses on measuring gastric insufflation volume and its relationship with oropharyngeal sealing pressure, which indicates how well the airway device seals and the risk of complications after surgery. Participants will be randomly assigned to receive either the Ambu AuraGain device or the I-gel device after anesthesia induction. Both devices serve as pathways for oxygen and anesthetic gases during surgery. The study evaluates outcomes like gastric antrum cross-sectional area at the end of surgery, leak pressure during the operation, time and attempts needed for insertion, and any postoperative complications within 24 hours. During the study, children will be monitored with assessments including ultrasound to measure the stomach area and tests for airway sealing pressure. Researchers will record details about device insertion and watch for any complications after surgery. Participation involves close observation during and shortly after surgery, with total involvement lasting through the surgical procedure and 24 hours afterward.

Gastric Insufflation Volume Using I-gel Versus Ambu AuraGain in Pediatric Patients Undergoing Elective Orthopedic Operations Under General Anesthesia